Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02651610
Title Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Peregrine Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Peregrine Pharmaceuticals Investigational Site Bakersfield California 93309 United States Details
Peregrine Pharmaceuticals Investigational Site Tinley Park Illinois 60487 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field